InMode to Engage Investors at BTIG MedTech Conference in Snowbird, Utah

InMode's Participation in BTIG MedTech Conference

InMode Ltd., a distinguished global player in medical technologies, is set to participate in the forthcoming BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference. This significant event will unfold on February 12, 2025, in the picturesque setting of Snowbird, Utah. Yair Malca, the company's Chief Financial Officer, will lead various investor meetings during this strategic gathering.

The BTIG conference is renowned for uniting industry leaders, innovators, and investors, providing a unique platform for discussing advancements in the medical and health sectors. InMode, recognized for its innovative approach to medical device technology, aims to strengthen its connections with stakeholders while sharing insights into its groundbreaking products and future strategies.

Yair Malca's participation highlights InMode's commitment to fostering investor relations and transparency. Interested investors are encouraged to reach out through their BTIG representatives for potential meetings, facilitating direct communication about InMode's growth, innovations, and market strategies.

InMode is celebrated for its advanced technologies, particularly in radiofrequency (RF) devices designed for diverse medical applications including plastic surgery, dermatology, gynecology, and more. The firm is dedicated to not only enhancing existing medical procedures but also developing new surgical methodologies that prioritize patient safety and satisfaction.

The forthcoming investor meetings will provide a comprehensive look at InMode's innovative solutions, including their latest developments in minimally invasive RF technology. Investors can expect discussions on how these advancements can revolutionize treatments across various medical fields.

For those keen on further information about the conference or details about InMode's participation, the company’s investor relations site offers additional insights.

InMode's proactive approach in attending industry conferences like BTIG underscores its ambition to not only lead in technological innovation but also in stakeholder engagement. The company’s commitment to pushing boundaries in medical technology signals potential growth and investment opportunities for interested parties.

As the date of the conference approaches, excitement builds around InMode's presentations and discussions. Stakeholders and potential investors will have the chance to witness the pioneering spirit of InMode and its dedication to transforming the landscape of medical technology.

For more about InMode and its expansive range of products, investors and interested parties can visit their official website at www.inmodemd.com. Stay tuned for updates following the conference, as InMode continues to make strides in the MedTech arena.

In conclusion, InMode's involvement in the BTIG MedTech Conference is set to be a pivotal moment for the company as it connects with investors and discusses its innovative technologies that define the future of medical treatment and patient care.